Marta Fernandez-Gil
La Paz, MD, Spain
Last Updated: 09/26/2026
Save publications for later
Sign Up
Not sure about your diagnosis?
Check Your Symptoms
Found 8 publications
NOD1 is a key mediator of atrial myopathy in heart failure.
Journal: Theranostics
Published: March 19, 2026
Early anti-inflammatory therapy in acute myocardial infarction: A network meta-analysis of timing-dependent effects in 23 randomized trials and 28,220 patients.
Journal: Atherosclerosis
Published: May 14, 2025
The Aryl Hydrocarbon Receptor Ligand FICZ Improves Left Ventricular Remodeling and Cardiac Function at the Onset of Pressure Overload-Induced Heart Failure in Mice.
Journal: International journal of molecular sciences
Published: April 27, 2022
Ca2+ mishandling in heart failure: Potential targets.
Journal: Acta physiologica (Oxford, England)
Published: October 20, 2020
Genetic Deletion of NOD1 Prevents Cardiac Ca2+ Mishandling Induced by Experimental Chronic Kidney Disease.
Journal: International journal of molecular sciences
Published: October 05, 2020
Innate Immune Receptors, Key Actors in Cardiovascular Diseases.
Journal: JACC. Basic to translational science
Published: February 24, 2020
Intracellular calcium mishandling leads to cardiac dysfunction and ventricular arrhythmias in a mouse model of propionic acidemia.
Journal: Biochimica et biophysica acta. Molecular basis of disease
Published: March 25, 2019
Deficiency of NOD1 Improves the β-Adrenergic Modulation of Ca2+ Handling in a Mouse Model of Heart Failure.
Journal: Frontiers in physiology
Published: March 01, 2018
Showing 1-8 of 8
Last Updated: 09/26/2026